Interestingly, KDM3A showed an anti-apoptotic function by erasing monomethylaion from p53K372, thus disturbing the stability of chromatin-bound p53 in cancer and promoted drug resistance [111], which brings new insight to understanding the role of KDM3A in lung cancer. This evidence concerns the gene KDM3A and lung carcinoma.